ITMR
Income statement / Annual
Last year (2020), Itamar Medical Ltd.'s total revenue was $41.03 M,
an increase of 31.28% from the previous year.
In 2020, Itamar Medical Ltd.'s net income was -$10.94 M.
See Itamar Medical Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$41.03 M |
$31.26 M |
$24.19 M |
$20.70 M |
$18.44 M |
$16.81 M |
$16.39 M |
$13.34 M |
$13.43 M |
| Cost of Revenue |
$12.32 M
|
$6.98 M
|
$5.73 M
|
$5.00 M
|
$4.98 M
|
$4.40 M
|
$4.80 M
|
$4.26 M
|
$3.80 M
|
| Gross Profit |
$28.71 M
|
$24.27 M
|
$18.46 M
|
$15.70 M
|
$13.46 M
|
$12.41 M
|
$11.59 M
|
$9.08 M
|
$9.62 M
|
| Gross Profit Ratio |
0.7
|
0.78
|
0.76
|
0.76
|
0.73
|
0.74
|
0.71
|
0.68
|
0.72
|
| Research and Development Expenses |
$6.00 M
|
$4.52 M
|
$3.64 M
|
$4.13 M
|
$3.23 M
|
$2.83 M
|
$2.02 M
|
$1.89 M
|
$1.69 M
|
| General & Administrative Expenses |
$8.50 M
|
$6.35 M
|
$5.25 M
|
$5.28 M
|
$5.36 M
|
$4.30 M
|
$4.63 M
|
$4.88 M
|
$2.55 M
|
| Selling & Marketing Expenses |
$24.55 M
|
$18.29 M
|
$12.70 M
|
$12.14 M
|
$14.04 M
|
$10.68 M
|
$8.44 M
|
$7.40 M
|
$5.69 M
|
| Selling, General & Administrative Expenses |
$33.05 M
|
$24.65 M
|
$17.95 M
|
$17.42 M
|
$19.40 M
|
$14.98 M
|
$13.07 M
|
$12.28 M
|
$8.23 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$849.00 K
|
$52.00 K
|
$113.00 K
|
$117.00 K
|
$217.00 K
|
| Operating Expenses |
$39.06 M
|
$29.17 M
|
$21.58 M
|
$21.55 M
|
$23.47 M
|
$17.87 M
|
$15.20 M
|
$14.29 M
|
$10.14 M
|
| Cost And Expenses |
$51.38 M
|
$36.15 M
|
$27.31 M
|
$26.55 M
|
$28.45 M
|
$22.27 M
|
$20.00 M
|
$18.54 M
|
$13.94 M
|
| Interest Income |
$713.00 K
|
$454.00 K
|
$93.00 K
|
$1.39 M
|
$547.00 K
|
$176.00 K
|
-$571.00 K
|
$714.00 K
|
$121.00 K
|
| Interest Expense |
$562.00 K
|
$284.00 K
|
$794.00 K
|
$4.43 M
|
$4.61 M
|
$4.19 M
|
$2.51 M
|
$4.83 M
|
$2.12 M
|
| Depreciation & Amortization |
$1.82 M
|
$1.29 M
|
$481.00 K
|
$509.00 K
|
$434.00 K
|
$367.00 K
|
$324.00 K
|
$400.00 K
|
$330.00 K
|
| EBITDA |
-$8.43 M |
-$3.66 M |
-$330.00 K |
-$280.00 K |
-$9.23 M |
$2.44 M |
-$313.00 K |
-$7.73 M |
$2.76 M |
| EBITDA Ratio |
-0.21
|
-0.12
|
-0.01
|
-0.01
|
-0.5
|
0.15
|
-0.02
|
-0.58
|
0.21
|
| Operating Income Ratio |
-0.25
|
-0.16
|
-0.13
|
-0.28
|
-0.54
|
-0.32
|
-0.22
|
-0.39
|
-0.04
|
| Total Other Income/Expenses Net |
-$468.00 K
|
-$337.00 K
|
$1.52 M
|
$632.00 K
|
-$4.26 M
|
$3.35 M
|
$458.00 K
|
-$7.76 M
|
$831.00 K
|
| Income Before Tax |
-$10.81 M
|
-$5.23 M
|
-$1.61 M
|
-$5.22 M
|
-$14.27 M
|
-$2.11 M
|
-$3.15 M
|
-$12.96 M
|
$316.00 K
|
| Income Before Tax Ratio |
-0.26
|
-0.17
|
-0.07
|
-0.25
|
-0.77
|
-0.13
|
-0.19
|
-0.97
|
0.02
|
| Income Tax Expense |
$127.00 K
|
$37.00 K
|
$124.00 K
|
$85.00 K
|
$131.00 K
|
$135.00 K
|
$124.00 K
|
-$44.00 K
|
-$201.00 K
|
| Net Income |
-$10.94 M
|
-$5.27 M
|
-$1.73 M
|
-$5.30 M
|
-$14.40 M
|
-$2.25 M
|
-$3.28 M
|
-$12.92 M
|
$517.00 K
|
| Net Income Ratio |
-0.27
|
-0.17
|
-0.07
|
-0.26
|
-0.78
|
-0.13
|
-0.2
|
-0.97
|
0.04
|
| EPS |
-0.79 |
-0.46 |
-0.17 |
-0.6 |
-1.65 |
-0.35 |
-0.56 |
-2.82 |
0.11 |
| EPS Diluted |
-0.79 |
-0.46 |
-0.17 |
-0.52 |
-1.65 |
-0.29 |
-0.46 |
-2.82 |
0.0315 |
| Weighted Average Shares Out |
$13.85 M
|
$11.54 M
|
$10.13 M
|
$8.80 M
|
$8.75 M
|
$6.39 M
|
$5.83 M
|
$4.58 M
|
$4.58 M
|
| Weighted Average Shares Out Diluted |
$13.85 M
|
$11.54 M
|
$10.13 M
|
$10.13 M
|
$8.75 M
|
$7.73 M
|
$7.15 M
|
$4.58 M
|
$16.42 M
|
| Link |
|
|
|
|
|
|
|
|
|
